Back to search results

SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)

Abroad (travel likely)Recruiting

Conditions

Gastrointestinal Cancer · Hematologic Cancer · Thoracic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Nadine J. McCleary, MD, MPH) · nj_mccleary@dfci.harvard.edu · (617) 632-6729
    Contact: Principal Investigator (Nadine J. McCleary, MD, MPH)

  • Dana-Farber Cancer Institute at St. Elizabeth's Medical Center, Brighton, Massachusetts, United States

    Contact: Study coordinator (Olga Kozyreva, MD) · olga_kozyreva@dfci.harvard.edu
    Contact: Principal Investigator (Olga Kozyreva, MD)

  • Dana-Farber Cancer Instiute - Merrimack Valley, Methuen, Massachusetts, United States

    Contact: Study coordinator (Pedro Sanz-Altamira, MD) · pedro_sanz-altamira@dfci.harvard.edu
    Contact: Principal Investigator (Pedro Sanz-Altamira, MD)
Study leads

  • Nadine J McCleary, MD MPH

    Principal Investigator

    Dana-Farber Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)